Skip to main content

Corsair Pharma

Sunnyvale, United States

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

$23.0M raised
Sep 2023
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Corsair Pharma

How much funding has Corsair Pharma raised?
Corsair Pharma has raised $23.0M in total funding. The most recent round was Series B. The last funding was announced in September 2023.
Who are Corsair Pharma's investors?
Corsair Pharma's investors include Primavera Capital Group, New Rhein, Junson Capital, Plaisance Capital Management, Midas Capital.
Where is Corsair Pharma headquartered?
Corsair Pharma is headquartered in Sunnyvale, United States.
What does Corsair Pharma do?
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.
What stage is Corsair Pharma at?
Corsair Pharma is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Corsair Pharma — Funding & Investors." VCBacked, September 20, 2023, https://www.vcbacked.co/company/corsair-pharma. Accessed July 1, 2026.
APA
VCBacked. (2023). Corsair Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/corsair-pharma
Wikipedia (cite web)
{{cite web |title=Corsair Pharma — Funding & Investors |url=https://www.vcbacked.co/company/corsair-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .